![Karen Chagin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karen Chagin
Direttore Tecnico/Scientifico/R&S presso
CONTEXT THERAPEUTICS INC.
Profilo
Karen Chagin is currently Chief Medical Officer at Context Therapeutics, Inc. Formerly, Dr. Chagin was Senior Vice President-Early-Stage Development at Adaptimmune Therapeutics Plc.
Education includes an undergraduate degree from the University of Pennsylvania and a doctorate from Temple University School of Medicine.
Posizioni attive di Karen Chagin
| Società | Posizione | Inizio |
|---|---|---|
| CONTEXT THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 09/06/2025 |
Precedenti posizioni note di Karen Chagin
| Società | Posizione | Fine |
|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Corporate Officer/Principal | - |
Formazione di Karen Chagin
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
14
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University School of Medicine
 Temple University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptimmune Therapeutics Plc
 Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
Context Therapeutics, Inc.
 Context Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops treatment options for women living with hormone-dependent cancer | Health Technology |
